Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: NANOMATRONIX LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-09-22 to 2025-06-30
Current total value of award: $1099993.64
Description: AWARD OF NANOMATRONIX'S DHA SBIR SEQUENTIAL PHASE II MEDICAL R&D CONTRACT FOR THE AMBIT PLATFORM:  AN IN VITRO SYSTEM FOR TRAUMATIC BRAIN INJURY R&D